Related Articles
Acquired resistance to imatinib and secondary KIT exon 13 mutation in gastrointestinal stromal tumour
Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours
Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach
Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines
Expression of stem cell factor in gastrointestinal stromal tumors: Implications for proliferation and imatinib resistance